BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15048082)

  • 1. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E; Paquet C; Beauchemin M; Bertrand R
    Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
    Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
    Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
    Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
    Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
    Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E; Sané AT; Steyaert A; Cimoli G; Bertrand R
    Biochem Cell Biol; 1997; 75(4):301-14. PubMed ID: 9493953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells.
    McDonnell MA; Wang D; Khan SM; Vander Heiden MG; Kelekar A
    Cell Death Differ; 2003 Sep; 10(9):1005-15. PubMed ID: 12934075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
    Schmitt E; Cimoli G; Steyaert A; Bertrand R
    Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1.
    Chau BN; Cheng EH; Kerr DA; Hardwick JM
    Mol Cell; 2000 Jul; 6(1):31-40. PubMed ID: 10949025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.
    Mashima T; Udagawa S; Tsuruo T
    J Cell Physiol; 2001 Sep; 188(3):352-8. PubMed ID: 11473362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade.
    Droin N; Beauchemin M; Solary E; Bertrand R
    Cancer Res; 2000 Dec; 60(24):7039-47. PubMed ID: 11156409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
    García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
    Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bak but not Bax is essential for Bcl-xS-induced apoptosis.
    Lindenboim L; Kringel S; Braun T; Borner C; Stein R
    Cell Death Differ; 2005 Jul; 12(7):713-23. PubMed ID: 15861188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
    Schmitt E; Steyaert A; Cimoli G; Bertrand R
    Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation.
    Bhattacharjee M; Acharya S; Ghosh A; Sarkar P; Chatterjee S; Kumar P; Chaudhuri S
    Int Immunol; 2008 Dec; 20(12):1489-505. PubMed ID: 18931364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of Bcl-2 family members to interact with Apaf-1 in normal and apoptotic cells.
    Conus S; Rossé T; Borner C
    Cell Death Differ; 2000 Oct; 7(10):947-54. PubMed ID: 11279541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins.
    Callus BA; Moujallad DM; Silke J; Gerl R; Jabbour AM; Ekert PG; Vaux DL
    J Mol Biol; 2008 Dec; 384(2):313-23. PubMed ID: 18835564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.
    Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA
    Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspases.
    Milosevic J; Hoffarth S; Huber C; Schuler M
    Oncogene; 2003 Oct; 22(44):6852-6. PubMed ID: 14534531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.